The lecture covers topics such as:
* Which is best - licensing or start-up?
* Who owns my invention?
* How do I work with my Tech Transfer Office?
More information: http://www.marsdd.com/Events/Event-Calendar/Ent101/2007/introcommercializing-20071107.html
Speaker: Tom Corr, Associate VP Commercialization, University of Waterloo Office of Research
Technology commercialization strategy for a multidisciplinary R&D institutions such as GRO and CRO under new research and business development (R&BD) paradigm
The Innovation Commercialization Process:A Case StudyCheryl Tulkoff
When people think of innovation, they frequently think of the “big idea” or product while overlooking the fact that innovation is really a process.
They think of innovation solely in the creative sense rather than considering the importance or even existence of an innovation methodology.
Countless examples exist of good inventions that never succeeded in the marketplace or failed to live up to expectations while lesser ones thrived.
Many of these failures could have been eliminated through use of an innovation commercialization process.
This presentation describes the process and demonstrates its application through a case study.
Within universities and research institutions there are no shortage of good ideas; but not all of those ideas make commercial sense. In this lecture, we explore what makes a technology worthwhile commercializing. We also touch on some of the lessons we can take from the university setting and apply to any start-up technology.
Speaker: Raphael Ronen, Commercialization Manager, The Innovations Group (TIG)
Part of the CIBC Presents Entrepreneurship 101 MaRS event series.
Read more on this event and catch the session video here: http://www.marsdd.com/Events/Event-Calendar/Ent101/2008/intro-tech-companies-10222008.html
SDSU Mgt747 FA13 summary - Technology Commercialization Ricardo dos Santos
Summary of SDSU's MBA class, MGT 747: Seminar in Technology Commercialization
Overview of major frameworks covered in class including disruptive innovation, customer development, business model generation and strategic choice canvas
Technology commercialization strategy for a multidisciplinary R&D institutions such as GRO and CRO under new research and business development (R&BD) paradigm
The Innovation Commercialization Process:A Case StudyCheryl Tulkoff
When people think of innovation, they frequently think of the “big idea” or product while overlooking the fact that innovation is really a process.
They think of innovation solely in the creative sense rather than considering the importance or even existence of an innovation methodology.
Countless examples exist of good inventions that never succeeded in the marketplace or failed to live up to expectations while lesser ones thrived.
Many of these failures could have been eliminated through use of an innovation commercialization process.
This presentation describes the process and demonstrates its application through a case study.
Within universities and research institutions there are no shortage of good ideas; but not all of those ideas make commercial sense. In this lecture, we explore what makes a technology worthwhile commercializing. We also touch on some of the lessons we can take from the university setting and apply to any start-up technology.
Speaker: Raphael Ronen, Commercialization Manager, The Innovations Group (TIG)
Part of the CIBC Presents Entrepreneurship 101 MaRS event series.
Read more on this event and catch the session video here: http://www.marsdd.com/Events/Event-Calendar/Ent101/2008/intro-tech-companies-10222008.html
SDSU Mgt747 FA13 summary - Technology Commercialization Ricardo dos Santos
Summary of SDSU's MBA class, MGT 747: Seminar in Technology Commercialization
Overview of major frameworks covered in class including disruptive innovation, customer development, business model generation and strategic choice canvas
Technology Commercialization and TransferJhon Lantaca
The presentation defines how transfer and commercialization of technology works. Innovation chain is also briefly described and relates to technology commercialization and transfer. The interested parties were defined but there are no legislation stated in the presentation as it only focuses on description, process, barriers, advantages and strategy.
Resources from Business Victoria's workshop giving early stage innovators information on the steps you need to take to turn your new product into a commercial reality.
Innovation & Technology Commercialization for NursesWhitney Power
This presentation was designed to inspire nurses to invent solutions to problems in the health care industry. It is presented by the Technology Commercialization Manager to nurses - and adapted for other audiences as needed. It was designed by Whitney Power to align with other department promotion/informational materials.
Business Development Tool Kit Presentation for New Media ManitobaJay Powell
Ever notice how some of your greatest business relationships emerge from conversations that started with no expectations to do business at all? There is a science behind this starting with a genuine desire to understand what the other person needs, how you can help them, and by undisputed universal law - help yourself. :) So how do you get started? Go-Go-Gadget Business Development!
On Tuesday, Feb 11th 2014, New Media Manitoba presents a special New Media Business Development evening with expert Jay Powell of The Powell Group from North Carolina. Jay will share his methodology and tools for creating a plan to generate business, maintain great relationships, and how to create a solid plan of attack when attending conferences.
We will discuss:
How to track business relationships
Who should do Business Development and why
Recommended tools for Business Development and Customer Relationships
What tools to avoid, and why
When to start (hint: now)
How to start (hint: attend this presentation)
Social media integration that makes your clients [heart] you
Attendees will Learn:
How to get the most out of a conference when building new business
How to maintain your network post-conference
5 important things to remember when developing your elevator pitch - and when to use it
Tools for all aspects of New Media Business Development
Technology Commercialization and TransferJhon Lantaca
The presentation defines how transfer and commercialization of technology works. Innovation chain is also briefly described and relates to technology commercialization and transfer. The interested parties were defined but there are no legislation stated in the presentation as it only focuses on description, process, barriers, advantages and strategy.
Resources from Business Victoria's workshop giving early stage innovators information on the steps you need to take to turn your new product into a commercial reality.
Innovation & Technology Commercialization for NursesWhitney Power
This presentation was designed to inspire nurses to invent solutions to problems in the health care industry. It is presented by the Technology Commercialization Manager to nurses - and adapted for other audiences as needed. It was designed by Whitney Power to align with other department promotion/informational materials.
Business Development Tool Kit Presentation for New Media ManitobaJay Powell
Ever notice how some of your greatest business relationships emerge from conversations that started with no expectations to do business at all? There is a science behind this starting with a genuine desire to understand what the other person needs, how you can help them, and by undisputed universal law - help yourself. :) So how do you get started? Go-Go-Gadget Business Development!
On Tuesday, Feb 11th 2014, New Media Manitoba presents a special New Media Business Development evening with expert Jay Powell of The Powell Group from North Carolina. Jay will share his methodology and tools for creating a plan to generate business, maintain great relationships, and how to create a solid plan of attack when attending conferences.
We will discuss:
How to track business relationships
Who should do Business Development and why
Recommended tools for Business Development and Customer Relationships
What tools to avoid, and why
When to start (hint: now)
How to start (hint: attend this presentation)
Social media integration that makes your clients [heart] you
Attendees will Learn:
How to get the most out of a conference when building new business
How to maintain your network post-conference
5 important things to remember when developing your elevator pitch - and when to use it
Tools for all aspects of New Media Business Development
New Business Development Proposal - Adding Project Portfolio Management (PPM)...Rolly Perreaux, PMP
This presentation is a New Business Development Proposal targeted to Microsoft Gold Partners considering adding the Project Portfolio Management competency to their consulting services.
Full video can also be viewed at: https://www.youtube.com/watch?v=uLIVzqI5d2Q
Presentation Agenda
- PPM Background
- How Microsoft PPM Works
- Market Analysis
- Value Added to Other Services
- PPM Competition
- What I Can Do For You
- Professional Bio
- Contact Information
A cross-industry inspiration set for brainstorms, new business development and strategy sessions. Note this a preview of what we make customised for our clients.
Created by Marc Heleven & Ramon Vullings - www.crossindustryinnovation.com/21ways
How to Use LinkedIn for New Business Development - Forward Progress - Dean De...Social Jack
This slidedeck supplemented the Forward Progress webinar, How to Use LinkedIn for New Business Development. In the webinar, Dean DeLisle, Founder and CEO of Forward Progress, described how those in business development can use LinkedIn to their advantage.
Old Business Development Vs New Business DevelopmentDeeallan
A look at what at 'Old BD v's New BD' specifically looking at the Recruitment sector. This presentation is for Recruiters, Consultants, HR and Employment Agencies, to see how the landscape for recruiting has changed, and what needs to be done today, to recruit successfully.
Presented by Dr. Tom Corr, CEO – Waterloo Research and Technology Park Accelerator Centre & Associate Vice President, Commercialization – University of Waterloo
Part of the Ontario Post Doctoral Fellowship Networking Event, October 6, 2008
TOPICS
Research Funding
Who Owns the Intellectual Property?
Commercialization Options
Dealing with VCs
Outcomes of Commercialization Efforts
Entrepreneurship 101: Commercializing University / Hospital TechnologiesMaRS Discovery District
Speaker: Tom Corr, DBA, MBA, ADipC, Director of Commercialization, IT and Communications, at Innovations at the University of Toronto
An audio presentation can be accessed by going to
http://www.marsdd.com/ent101
and clicking on the October 17, 2006 session:
"Entrepreneurship 101 - An Introduction to Commercializing University/Hospital Technologies"
Speaker: Raphael Ronen, Commercialization Manager, The Innovations Group (TIG)
Within universities and research institutions there are no shortage of good ideas; but not all of those ideas make commercial sense. In this lecture, we explore what makes a technology worthwhile commercializing. We also touch on some of the lessons we can take from the university setting and apply to any start-up technology.
Part of the CIBC Presents Entrepreneurship 101 lecture series: http://www.marsdd.com/ent101
Common Pitfalls and Key Considerations in Getting (and Keeping) Intellectual ...UCICove
About UCI Applied Innovation:
UCI Applied Innovation is a dynamic, innovative central platform for the UCI campus, entrepreneurs, inventors, the business community and investors to collaborate and move UCI research from lab to market.
About the Cove @ UCI:
To accelerate collaboration by better connecting innovation partners in Orange County, UCI Applied Innovation created the Cove, a physical, state-of-the-art hub for entrepreneurs to gather and navigate the resources available both on and off campus. The Cove is headquarters for UCI Applied Innovation, as well as houses several ecosystem partners including incubators, accelerators, angel investors, venture capitalists, mentors and legal experts.
Follow us on social media:
Facebook: @UCICove
Twitter: @UCICove
Instagram: @UCICove
LinkedIn: @UCIAppliedInnovation
For more information:
cove@uci.edu
http://innovation.uci.edu/
Strong patent protection is essential for a start-up biotechnology company and can be a valuable company asset. However, it is also expensive, with costs ranging from tens to hundreds of thousands of dollars over time. This session will focus on how to get the most out of your patent dollars.
This session presentation is available in audio format here: http://www.marsdd.com/bioent/dec4
Training for a career in science begins with formal theoretical and practical instruction at an academic institution, often followed by advanced training and eventual employment also at an academic institution. This career path is one which has been historically taken by most scientists.
In recent years, increasing numbers of academic scientists are choosing commercial laboratories to pursue their research careers. This shift in career path is driven to a large degree by the eroding of financial support for academic scientists, as evidenced by the downward trend in the funding rate for grants submitted to the NIH, NSF, and private foundations. Perhaps the greatest challenge for an academic scientist contemplating a move to a commercial laboratory is to adjust their thinking of ‘doing science for science sake’ to ‘doing science for commercializing a product’.
This insightful Webinar will cover areas to be considered when making this career change, including the culture of the commercial laboratory working environment, career advancement, scientific recognition, mentoring, and availability of opportunities.
5 Key Take-Aways:
Similarities and difference between academic and commercial laboratory working environments
Suggestions on how to increase your autonomy and independence in conducting research at a commercial laboratory
How to ‘hedge your bets’ so that deadlines and milestones are reached
Balancing publishing and intellectual property generation
The difference in costs between academic and commercial laboratory research
Who Should Attend:
Any academic PI, scientist, post-doc, graduate student, technician contemplating a move from a university-based research laboratory to a commercial biotechnology or pharmaceutical development laboratory.
David Dorsey (Osage University Partners) - Who are the founders of university...Startupfest
Osage University Partners is a venture capital firm that invests in university startups. Over the past 9 years they have spoken with about 5000 teams attempting to start a business based on research. In this talk, David will use some of their own data to discuss the different roles that the scientific founder play in the commercialization effort. He will also talk about what they, as investors, look for in a CEO when they are deciding to fund a university startup, using a fictional example for discussion.
Commercialisation Director, Colin Hunsley, was invited to Krakow IP Symposium to talk on IP Commercialisation. IN particular, this presentation focuses on commercialising publically funded R&D and the role of IP.
Technology Transfer for Knowledge Translation PractitionersJennifer Flagg
This presentation is geared towards inventors and professionals who are trying to move inventions from the lab to the market. First, we identify the major phases of the new product development process. Next, we describe various forms of intellectual property protection and when they would be used. Finally, we articulate how the Knowledge to Action model can be used to define tech transfer activities.
How To Protect Your Company's Intellectual PropertySecureDocs
This presentation covers cost-effective patent protection for inventions worldwide and protection tactics for unpatented trade secrets. It also gives a compelling argument for why companies should go against the status quo when filing for patents which can help save money and speed up the total patenting process.
Open innovation fast forward seminar jg 2013Alan Scrase
Open Innovation Seminar (29th January 2013):
The “Open Innovation” paradigm is being widely proclaimed as the answer to the issues of expediting commercial success from technology and strengthening industrial competitiveness. However, the term can mean different things to different people according to their sector of industry, place in value chain, and company size. Open innovation sounds very attractive in theory, but in practice, unless well planned by all participants, can give rise to some unanticipated logistical and management issues. Different real scenarios from the speaker’s experience are presented and discussed.
Dr. James Green
Director of Intellectual Property, Ilika plc
Dr Green graduated from Bristol University. He has 42 years experience of innovation and IP. Initially, in industry and contract research, he was later appointed Secretary of the CBI Research & Technology Committee. In 1984, he joined Research Corporation’s venture with 3i plc. He then moved to Ohio as Vice President, Competitive Technologies Inc, returning later to Britain at ANGLE Technology. He relocated to the US in 2001, as Director of Development at Cumberland Pharmaceuticals Inc. Returning to the UK, he set up Seges Development Company Ltd, and is currently Director of Intellectual Property at Ilika plc.
Dr. Craig Kenesky, a patent attorney with the life science practice at WSGR in New York, delivers a presentation on "IP and the Biopharma Startup" at the October 29 iCAN-Global Entrepreneur's Breakfast Forum.
Learn how to grab investors’ attention with great stories. In this session, we discuss how to build and deliver an effective pitch to help you find financing for your venture or to sell your product to customers. We cover the essentials of a strong pitch deck and identify the elements of good communication that successful startups use.
Key topics covered: Pitch deck, storytelling, presenting
Learn how to grab investors’ attention with great stories. In this session, we discuss how to build and deliver an effective pitch to help you find financing for your venture or to sell your product to customers. We cover the essentials of a strong pitch deck and identify the elements of good communication that successful startups use.
Key topics covered: Pitch deck, storytelling, presenting
As an entrepreneur, you need to develop a long-term financing strategy for your business. This session helps you determine what financing approach is right for you.
Key topics covered: bootstrapping, angel investment
As an entrepreneur, you need to develop a long-term financing strategy for your business. This session helps you determine what financing approach is right for you.
Key topics covered: bootstrapping, angel investment
As a startup owner, you can’t afford to be a bad leader. This lecture addresses the fundamentals of steering your company through the four stages of the business cycle until it is self-sustaining. Learn how to inspire others, set clear goals (and stay focused), communicate clearly with your team, and execute your role effectively.
A successful startup requires the best possible talent. Great people are out there, but how do you find them? And how do you make them want to work for you? This session focuses on identifying the positions necessary for your startup to scale, attracting the best talent using limited resources, and making sure you have a plan in place to find the right people for the job.
A successful startup requires the best possible talent. Great people are out there, but how do you find them? And how do you make them want to work for you? This session focuses on identifying the positions necessary for your startup to scale, attracting the best talent using limited resources, and making sure you have a plan in place to find the right people for the job.
A successful startup requires the best possible talent. Great people are out there, but how do you find them? And how do you make them want to work for you? This session focuses on identifying the positions necessary for your startup to scale, attracting the best talent using limited resources, and making sure you have a plan in place to find the right people for the job.
Learn how to build your financial plan from the bottom up. Learn the basics about startup finances, including knowing how to forecast revenue and growth, understanding different types of financial models, and identifying what metrics and milestones you should track.
https://www.marsdd.com/entrepreneurship-101/
Learn how to build your financial plan from the bottom up. Learn the basics about startup finances, including knowing how to forecast revenue and growth, understanding different types of financial models, and identifying what metrics and milestones you should track.
https://www.marsdd.com/entrepreneurship-101/
Learn how to build your financial plan from the bottom up. Learn the basics about startup finances, including knowing how to forecast revenue and growth, understanding different types of financial models, and identifying what metrics and milestones you should track.
https://www.marsdd.com/entrepreneurship-101/
The number one cause of startup death is premature scaling. In this session, we talk about the importance of customer validation and timing in your go-to-market strategy. The most effective growth strategy for your startup will depend on the market in which you operate and the stage of your business, and knowing which lever for growth you can pull. We’ll cover all this and more in Scaling Your Startup.
Key topics: Growth strategy, calculating risk, accessing new markets
The number one cause of startup death is premature scaling. In this session, we talk about the importance of customer validation and timing in your go-to-market strategy. The most effective growth strategy for your startup will depend on the market in which you operate and the stage of your business, and knowing which lever for growth you can pull. We’ll cover all this and more in Scaling Your Startup.
Key topics: Growth strategy, calculating risk, accessing new markets
The number one cause of startup death is premature scaling. In this session, we talk about the importance of customer validation and timing in your go-to-market strategy. The most effective growth strategy for your startup will depend on the market in which you operate and the stage of your business, and knowing which lever for growth you can pull. We’ll cover all this and more in Scaling Your Startup.
Key topics: Growth strategy, calculating risk, accessing new markets
It’s one thing to sell to customers—it’s another to negotiate with business partners, corporate lawyers and investors. In this Entrepreneurship 101 lecture, we discuss the art of the sale in depth and give tips and tricks on how you can succeed when negotiating with various stakeholders.
Key topics covered: Partnerships, corporate agreements and negotiating.
It’s one thing to sell to customers—it’s another to negotiate with business partners, corporate lawyers and investors. In this Entrepreneurship 101 lecture, we discuss the art of the sale in depth and give tips and tricks on how you can succeed when negotiating with various stakeholders.
Key topics covered: Partnerships, corporate agreements and negotiating.
It’s one thing to sell to customers—it’s another to negotiate with business partners, corporate lawyers and investors. In this Entrepreneurship 101 lecture, we discuss the art of the sale in depth and give tips and tricks on how you can succeed when negotiating with various stakeholders.
Key topics covered: Partnerships, corporate agreements and negotiating.
How are you going to sell your product? In this session, we explore sales and the principles of selling value to your customers. We discuss how your sales funnel fits into your overall marketing mix.
Get tips on:
Making sales calls
Closing a sale
Following up with potential customers
We’ll also talk about developing relationships as part of the sales process, using both social and offline examples.
Key topics: Sales funnel, the sales call and social selling.
The Art & Science of Sales: Tips, Tricks & Tools - Entrepreneurship 101MaRS Discovery District
How are you going to sell your product? In this session, we explore sales and the principles of selling value to your customers. We discuss how your sales funnel fits into your overall marketing mix.
Get tips on:
Making sales calls
Closing a sale
Following up with potential customers
We’ll also talk about developing relationships as part of the sales process, using both social and offline examples.
Key topics: Sales funnel, the sales call and social selling.
How are you going to sell your product? In this session, we explore sales and the principles of selling value to your customers. We discuss how your sales funnel fits into your overall marketing mix.
Get tips on:
Making sales calls
Closing a sale
Following up with potential customers
We’ll also talk about developing relationships as part of the sales process, using both social and offline examples.
Key topics: Sales funnel, the sales call and social selling.
"𝑩𝑬𝑮𝑼𝑵 𝑾𝑰𝑻𝑯 𝑻𝑱 𝑰𝑺 𝑯𝑨𝑳𝑭 𝑫𝑶𝑵𝑬"
𝐓𝐉 𝐂𝐨𝐦𝐬 (𝐓𝐉 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬) is a professional event agency that includes experts in the event-organizing market in Vietnam, Korea, and ASEAN countries. We provide unlimited types of events from Music concerts, Fan meetings, and Culture festivals to Corporate events, Internal company events, Golf tournaments, MICE events, and Exhibitions.
𝐓𝐉 𝐂𝐨𝐦𝐬 provides unlimited package services including such as Event organizing, Event planning, Event production, Manpower, PR marketing, Design 2D/3D, VIP protocols, Interpreter agency, etc.
Sports events - Golf competitions/billiards competitions/company sports events: dynamic and challenging
⭐ 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐬:
➢ 2024 BAEKHYUN [Lonsdaleite] IN HO CHI MINH
➢ SUPER JUNIOR-L.S.S. THE SHOW : Th3ee Guys in HO CHI MINH
➢FreenBecky 1st Fan Meeting in Vietnam
➢CHILDREN ART EXHIBITION 2024: BEYOND BARRIERS
➢ WOW K-Music Festival 2023
➢ Winner [CROSS] Tour in HCM
➢ Super Show 9 in HCM with Super Junior
➢ HCMC - Gyeongsangbuk-do Culture and Tourism Festival
➢ Korean Vietnam Partnership - Fair with LG
➢ Korean President visits Samsung Electronics R&D Center
➢ Vietnam Food Expo with Lotte Wellfood
"𝐄𝐯𝐞𝐫𝐲 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐚 𝐬𝐭𝐨𝐫𝐲, 𝐚 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐣𝐨𝐮𝐫𝐧𝐞𝐲. 𝐖𝐞 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐚𝐭 𝐬𝐡𝐨𝐫𝐭𝐥𝐲 𝐲𝐨𝐮 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐨𝐮𝐫 𝐬𝐭𝐨𝐫𝐢𝐞𝐬."
Remote sensing and monitoring are changing the mining industry for the better. These are providing innovative solutions to long-standing challenges. Those related to exploration, extraction, and overall environmental management by mining technology companies Odisha. These technologies make use of satellite imaging, aerial photography and sensors to collect data that might be inaccessible or from hazardous locations. With the use of this technology, mining operations are becoming increasingly efficient. Let us gain more insight into the key aspects associated with remote sensing and monitoring when it comes to mining.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
Explore our most comprehensive guide on lookback analysis at SafePaaS, covering access governance and how it can transform modern ERP audits. Browse now!
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Taurus Zodiac Sign_ Personality Traits and Sign Dates.pptxmy Pandit
Explore the world of the Taurus zodiac sign. Learn about their stability, determination, and appreciation for beauty. Discover how Taureans' grounded nature and hardworking mindset define their unique personality.
Attending a job Interview for B1 and B2 Englsih learnersErika906060
It is a sample of an interview for a business english class for pre-intermediate and intermediate english students with emphasis on the speking ability.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Entrepreneurship 101: Introduction to Technology Commercialization
1.
2. `
ONTARIO RESEARCH INSTITUTION
COMMERCIALIZATION
Presented by:
Dr. Tom Corr
CEO – Waterloo Research and Technology Park Accelerator Centre &
Associate Vice President, Commercialization – University of Waterloo
tcorr@uwaterloo.ca
November 7, 2007
3. TOPICS
• Research Funding
• Who Owns the Intellectual Property?
• Commercialization Options
• Dealing with VCs
• Outcomes of Commercialization Efforts
4. Research Funding
• Where does the funding come from (OCE, NSERC,
CIHR, etc.).
• Governments spread around the $ (federal and
provincial) usually based upon competitive applications.
• Range from $10K POP grants to multi-year, multi-million
long term funding.
• Most researchers spend a lot of time applying for grant $
to fund their research (i.e. pay for equipment, students,
and conferences).
5. • At research institutions in Canada - typically the
researchers own the IP, or the institution owns the IP,
or some combination of the two.
• Institution owned: McMaster (researcher can negotiate
with the university for ownership and
commercialization rights)
• Researcher owned: Waterloo
• Joint Ownership: UHN (1/3 to researchers, 1/3 to UHN,
and 1/3 to researchers department)
• Joint Ownership: UofT (50/50 - Researchers/UofT)
until Disclosed, and then Researcher has the option to
own.
IP Ownership Policies
6. IP Commercialization if University Involved in Commercialization
• Waterloo: 25% to University and 75% to Researchers
• UofT: 60% to University and 40% to Researchers
IP Commercialization if University NOT Involved in
Commercialization
(i.e. researchers commercialize on their own IP)
• Waterloo: 0% to University and 100% to Researchers
• UofT: 25% to University and 75% to Researchers
These are just 2 examples – all universities have their own
ownership and commercialization policies.
.
7. IP Ownership is a HUGE issue when it
comes to commercialization….
Who owns what…future development
• Researchers are typically obligated to DISCLOSE their research to the
institution with the institution keeping rights for further research and
teaching only.
• Many times disagreements between researchers as to who invented
what, and the % of any proceeds from commercialization that should
go to each– especially difficult to deal with when researchers include
profs and their students.
• Clear ownership is needed before investors will fund or they will walk
away from the deal.
• Future development of same IP is also a big issue as some
researchers (students) may come and go, which may result in issues
about assigning interest in new but related IP at a future date.
8. What are a lot of professors focused on?
• Younger profs concerned about getting tenure.
• How do they get it:
- Publishing papers
- Doing more research
- Teaching
Commercialization of IP is not always high on
their list – has implications for businesses who
want to license/buy the IP and move the IP
forward in conjunction with the researchers.
9. What’s in it for the researchers?
- Royalties (At UofT 60%-75% of royalties go to
the researchers, at UW 75%-100%)
- Equity in start-up
- More $ to do research
- Peer recognition
Does little to get tenure other than as a result of
the papers that may be published on the on-
going research, and sometimes publishing in
itself is a huge problem in commercialization.
10. What do Technology Transfer operations at
Universities do in the commercialization process?
• Pay to Protect IP – patents, trademarks,
copyrights.
• Assist in the developing of Business Plans and
commercialization strategy.
• Assist in getting additional grant funding to
further develop IP (sometimes mandatory that
the technology transfer office is involved
NSERC –i2i).
• Create start-up company when appropriate
vehicle for commercialization.
• Assist in raising financing for company.
• Negotiate agreements with licensees.
11. Why do some research institutions only commercialize
~10% of the researchers inventions?
• Intellectual Property (IP or Invention) is pure
research with no market potential.
• Market is too small to bother going after.
• Existing patents may not allow for the IP to be
practiced.
• Researchers have unrealistic expectations that
the institution cannot meet (e.g value of IP)
However, researchers can take ownership of
their IP and commercialize it themselves
should they choose.
13. Licensing
Typical Agreement Terms and Conditions:
• Licensing (to start-ups or large corporations):
- royalty paid to researchers (and university if
they are involved in the commercialization)
based upon sales attributable to IP – typically
around 5% of sales.
• Milestones – if license is exclusive then
minimum royalties typically apply as well as
development milestones (especially in drug
development).
14. Spin-Off Company
New Company Created to:
• License researchers technology and
build a company around it.
• Fund further research at institution with
the aim of developing/improving
technologies for license by the company.
15. SPIN-OFF’s
- Company formed in which researchers may be a
shareholder.
- Typically key researcher will be acting head of
R&D (most researchers don’t want to leave the
university except temporarily on paid sabbatical).
- Given priorities of researchers it is sometimes
problematic to get them on the critical path to
commercialization – they sometimes get in the
way and slow the commercialization process.
16. Spin-Off’s
• Until mid-1990s most research institutions IP
was licensed to large companies (i.e. not spin-
offs) that were in business related to the IP.
• Some research institutions still have policy not to
license IP to spin-offs (risk involved in licensing
IP to under-funded start-up).
17. Industry Need
• Some large established companies not
well suited to generating new lines of
business and divisions.
• Large companies look to M&A (Mergers
and Acquisitions) as an alternative.
• Companies will pay premium for small
companies that are synergistic with their
business mission.
18. What to consider when looking at the
Spin-Off alternative to licensing?
• Lack of suitable receptor capacity (licensee) for IP.
• Is IP a solid foundation for a new company and
potential platform for additional synergistic IP?
• Potential to be a $50 million+ public company?
• Can funding and management be attracted to spin-
off.
• Potential return to inventors, research institution,
and investors.
19. Other Factors
• Spin-offs may create more value quicker, as the
potential value of shares may have more upside
than licensing.
• Royalties may flow sooner on licensing deals.
• Licensing will have lot of up-front work but less
than spin-off once agreements negotiated.
Bottom Line – Spin-offs take more effort than
licensing, but have the potential for bigger upside in
the long term.
20. Research Institutions Potential Role in Spin-Offs
• Impetus may come from the research institution,
inventors, or investors to create spin-off.
• If formed by research institution, there is the need for a
“champion” to be identified to look after everyone’s
interest. Must have the skills to deal with start-up
companies.
• Provide patent and legal financing.
• Research Institutions role may range from very little, to
creation and on-going management of company -
especially until funding and management in place.
21. Research Institutions Potential Role in Spin-Offs
• Determine financing alternatives and pursue
them (government, angels, VCs).
• Promote the spin-off and potentially look for
other IP.
• Continuously consider the value of its
shareholding, the impact of decisions on its
share value, and look to maximize value and for
exit strategy (IPO or company sale).
22. Cross Cultural Issues
Investors need to understand:
• IP requires time and investment before ready to
market.
• Likely a requirement to fund on-going
commercially relevant IP research and
development.
• Researchers want freedom of research and
control over their IP.
• Researchers need to publish results.
23. Cross Cultural Issues
Researchers need to understand:
• Focus on marketing and market related issues is
essential.
• Market considerations require attention when R&D is
underway.
• Significant funds need to be raised and invested to
develop products and to market them.
• Companies need to operate at an accelerated time scale
compared to academia.
24. Spin-Offs vs. Licensing - Summary
• Spin-Off’s are time consuming, risky, and take
up a lot of time that may or may not, be better
spent on licensing the IP if that option available.
• Have potential for big upside under right
circumstances.
• Decision to do spin-off needs careful
consideration and commitment from all parties
involved.
25. It takes 10 times more time to
manage a spin-off than it does a
licensing transaction
26. Investors – what do they think?
• Attitude is everything…unless the
company is paramount in mind of
entrepreneurs and researchers - don’t
invest.
• Getting customers and learning from them
is the best way to guide commercialization
– not just doing more research without
industry input.
27. Investors – What do they think?
• Close governance is extremely important
to force focus.
• Dilution is forgotten if successful and
irrelevant if a failure.
• While plans change (and so they should),
having one is helpful.
28. Recurring pitfalls and themes
• Overestimating the science/technology and one’s
capabilities
– Lack of realism regarding the actual stage of development
of the science/technology
• Poor understanding of the customer and his/her
value chain
– Proactive ignorance of challenges involved in developing
and realizing value
• Disconnect between business and the science
– Underweighting of importance of demonstrating
progressive commercial achievement
29. • Late stage grants (OCE, NSERC).
• Some granting agencies getting wiser and some of them fund
the companies licensing the IP – not funding the researchers
as they want to see commercialization of the IP nor more
research done.
• Angel Investors – typically invest in start-ups where they have
had prior experience with their marketplace (www.tvg.org).
Valuation issues – convertible debt.
• Funding also comes from start-ups and large corporations.
• Spin-offs – funding from shareholders/early stage investors
Where does the money come from at this
EARLY stage?
30. - typically look to make minimum investment of $1
- $5 million (over time) and want to do later
stage deals (revenues, customers)
- Looking to get 10 times their money back in 5
years
- Fund based upon milestones and future
valuations based upon milestones (beware the
ratchet)
Later Stage VC Funding
31. Later Stage VC Funding
- Initial valuations based upon all the classic
models (e.g. sales multiples, DCFs.
earnings multiples, etc) don’t work.
However forget all that as most start-ups
are worth $1.5 - $2 million to VCs – very
rarely do you see exceptions.
- Important that expectations are agreed to
by both sides – you have both got a new
partner in your life.
32. Deal and Negotiation - steps/process/documentation
• Business plan development
• Who to take to
• Negotiations
• Term Sheet
• More Negotiations
• Close
REMEMBER – 1 deal in 100 – 200 that looks for VC
funding actually gets funding.
The majority should forget about VC funding and try
bootstrapping – read ART OF THE START by GUY
KAWSAKI.
33. Why deals fall apart
- Investors don’t have comfort in IP
ownership
- Investors don’t realize that they are
dealing with research – as opposed to
detailed business plans and products that
are ready to go.
- Long time to market which equates to lots
of investment – especially for life sciences
deals – regulatory issues.
34. Why deals fall apart
- Researchers don’t invest time that is required.
- Researchers lose interest in the research and
move on to other areas of research interest or
move to other institutions.
- Patents get rejected (more important in
institutional research than in typical IT deals).
- Expectations that grant $ will fund operations
which it seldom does
35. SUMMARY
- Most Canadian research institutions have a
researcher friendly policy which allows the
researcher to gain most of the financial
upside from their inventions.
- There is a lot of commercialization
assistance available for researchers who are
coachable (MARS, Accelerator Centre in
Waterloo, OCE, technology transfer offices,
etc).
- The investment community is always looking
for good IP to invest in but don’t just focus
on VCs for funding.
36. SUMMARY
- Successful research typically leads to more
funding for on-going research – huge focus
on commercialization outcomes by granting
agencies.
- More funding is being put into Canadian
research and commercialization than ever
before.
There has never been a better time for
commercialization in terms of the support
and funding available.